{"id":"https://openalex.org/W2117239059","doi":"https://doi.org/10.1093/jnci/djn151","title":"Randomized Phase 3 Trial of Fluorouracil, Epirubicin, and Cyclophosphamide Alone or Followed by Paclitaxel for Early Breast Cancer","display_name":"Randomized Phase 3 Trial of Fluorouracil, Epirubicin, and Cyclophosphamide Alone or Followed by Paclitaxel for Early Breast Cancer","publication_year":2008,"publication_date":"2008-05-27","ids":{"openalex":"https://openalex.org/W2117239059","doi":"https://doi.org/10.1093/jnci/djn151","mag":"2117239059","pmid":"https://pubmed.ncbi.nlm.nih.gov/18505968"},"language":"en","primary_location":{"id":"doi:10.1093/jnci/djn151","doi":"https://doi.org/10.1093/jnci/djn151","is_oa":true,"landing_page_url":"https://doi.org/10.1093/jnci/djn151","pdf_url":"https://academic.oup.com/jnci/article-pdf/100/11/805/7682226/djn151.pdf","source":{"id":"https://openalex.org/S98010888","display_name":"JNCI Journal of the National Cancer Institute","issn_l":"0027-8874","issn":["0027-8874","1460-2105"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-b","doyens","jufo-3","ki-jl-2","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310311648","host_organization_name":"Oxford University Press","host_organization_lineage":["https://openalex.org/P4310311648","https://openalex.org/P4310311647"],"host_organization_lineage_names":["Oxford University Press","University of Oxford"],"type":"journal"},"license":"cc-by-nc","license_id":"https://openalex.org/licenses/cc-by-nc","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"JNCI Journal of the National Cancer Institute","raw_type":"journal-article"},"volume":null,"type":"article","is_traditional":true,"indexed_in":["crossref","pubmed"],"open_access":{"is_oa":true,"oa_status":"hybrid","oa_url":"https://academic.oup.com/jnci/article-pdf/100/11/805/7682226/djn151.pdf","any_repository_has_fulltext":true},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5100671433","display_name":"Miguel Mart\u00edn","orcid":"https://orcid.org/0000-0001-9237-3231","observed_orcids":["https://orcid.org/0000-0001-9237-3231"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"M. Martin","raw_affiliation_strings":["Servicio de Oncologia Medica, Hospital Universitario San Carlos, Ciudad Universitaria s/n, 28040 Madrid, Spain. mmartin@geicam.org","Servicio de Oncologia Medica, Hospital Universitario San Carlos, Ciudad Universitaria s/n, 28040 Madrid, Spain"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Servicio de Oncologia Medica, Hospital Universitario San Carlos, Ciudad Universitaria s/n, 28040 Madrid, Spain. mmartin@geicam.org","institution_ids":[]},{"raw_affiliation_string":"Servicio de Oncologia Medica, Hospital Universitario San Carlos, Ciudad Universitaria s/n, 28040 Madrid, Spain","institution_ids":[]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5071202334","display_name":"\u00c1lvaro Rodr\u00edguez-Lescure","orcid":"https://orcid.org/0000-0002-6823-5290","observed_orcids":["https://orcid.org/0000-0002-6823-5290"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"A. Rodriguez-Lescure","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5018141942","display_name":"A. Ruiz","orcid":"https://orcid.org/0000-0002-0232-1890","observed_orcids":["https://orcid.org/0000-0002-0232-1890"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"A. Ruiz","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5036532311","display_name":"Emilio Alba","orcid":"https://orcid.org/0000-0002-3364-2603","observed_orcids":["https://orcid.org/0000-0002-3364-2603"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"E. Alba","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5031504621","display_name":"Lourdes Calvo","orcid":"https://orcid.org/0000-0001-8314-0241","observed_orcids":["https://orcid.org/0000-0001-8314-0241"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"L. Calvo","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5045301167","display_name":"Manuel Ru\u00edz\u2010Borrego","orcid":"https://orcid.org/0000-0002-1181-5622","observed_orcids":["https://orcid.org/0000-0002-1181-5622"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"M. Ruiz-Borrego","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5109911143","display_name":"Blanca Mun\u00e1rriz","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"B. Munarriz","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5101637615","display_name":"Cesar Augusto Rodriguez","orcid":"https://orcid.org/0000-0003-3484-4829","observed_orcids":["https://orcid.org/0000-0003-3484-4829"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"C. A. Rodriguez","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5018612347","display_name":"Carmen Crespo","orcid":"https://orcid.org/0000-0002-7634-2002","observed_orcids":["https://orcid.org/0000-0002-7634-2002"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"C. Crespo","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5033029074","display_name":"Enrique de \u00c1lava","orcid":"https://orcid.org/0000-0001-8400-046X","observed_orcids":["https://orcid.org/0000-0001-8400-046X"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"E. de Alava","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5107839380","display_name":"Jos\u00e9 Antonio L\u00f3pez Garc\u00eda\u2010Asenjo","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"J. A. Lopez Garcia-Asenjo","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5082014328","display_name":"M. Guitian","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"M. D. Guitian","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5069050584","display_name":"Sergio M. Almenar","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"S. Almenar","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5101598110","display_name":"Javier Gonz\u00e1lez-Palacios","orcid":"https://orcid.org/0000-0002-8099-8469","observed_orcids":["https://orcid.org/0000-0002-8099-8469"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"J. F. Gonzalez-Palacios","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":null,"display_name":"F. Vera","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"F. Vera","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5090159813","display_name":"Jos\u00e9 Palacios","orcid":"https://orcid.org/0000-0002-6730-5066","observed_orcids":["https://orcid.org/0000-0002-6730-5066"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"J. Palacios","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5061073254","display_name":"Manuel Ramos","orcid":"https://orcid.org/0000-0001-7264-8234","observed_orcids":["https://orcid.org/0000-0001-7264-8234"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"M. Ramos","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":null,"display_name":"J. M. Gracia Marco","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"J. M. Gracia Marco","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5026179323","display_name":"Ana M. Lluch","orcid":"https://orcid.org/0000-0003-2766-407X","observed_orcids":["https://orcid.org/0000-0003-2766-407X"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"A. Lluch","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5034457114","display_name":"Ivonne \u00c1lvarez","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"I. Alvarez","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5009333628","display_name":"Miguel \u00c1ngel Segu\u00ed","orcid":"https://orcid.org/0000-0002-5103-6746","observed_orcids":["https://orcid.org/0000-0002-5103-6746"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"M. A. Segui","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5019667620","display_name":"Jose Ignacio Mayordomo","orcid":"https://orcid.org/0000-0001-9495-2843","observed_orcids":["https://orcid.org/0000-0001-9495-2843"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"J. I. Mayordomo","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5067802897","display_name":"Angelyn Anton","orcid":"https://orcid.org/0000-0002-8459-7961","observed_orcids":["https://orcid.org/0000-0002-8459-7961"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"A. Anton","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5045600753","display_name":"Jos\u00e9 Manuel Baena","orcid":"https://orcid.org/0000-0002-7199-5186","observed_orcids":["https://orcid.org/0000-0002-7199-5186"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"J. M. Baena","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5015935217","display_name":"A. Plazaola","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"A. Plazaola","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5030075643","display_name":"A. Modolell","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"A. Modolell","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5075417962","display_name":"A. Pelegr\u00ed","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"A. Pelegri","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5109965886","display_name":"Jose Ram\u00f3n Mel","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"J. R. Mel","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5068189051","display_name":"Enrique Aranda","orcid":"https://orcid.org/0000-0002-5471-2842","observed_orcids":["https://orcid.org/0000-0002-5471-2842"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"E. Aranda","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5068323742","display_name":"Encarna Adrover","orcid":"https://orcid.org/0000-0001-8676-8560","observed_orcids":["https://orcid.org/0000-0001-8676-8560"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"E. Adrover","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":null,"display_name":"J. V. Alvarez","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"J. V. Alvarez","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5073275232","display_name":"Jos\u00e9 Luis Garc\u00eda Puche","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"J. L. Garcia Puche","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5064901053","display_name":"Pedro S\u00e1nchez\u2010Rovira","orcid":"https://orcid.org/0000-0003-2658-1467","observed_orcids":["https://orcid.org/0000-0003-2658-1467"]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"P. Sanchez-Rovira","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":null,"display_name":"S. Gonzalez","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"S. Gonzalez","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"middle","author":{"id":"https://openalex.org/A5078161203","display_name":"Jos\u00e9 Manuel L\u00f3pez-Vega","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"J. M. Lopez-Vega","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]},{"author_position":"last","author":{"id":null,"display_name":"On behalf of the GEICAM 9906 Study Investigators","orcid":null,"observed_orcids":[]},"institutions":[],"countries":[],"is_corresponding":false,"raw_author_name":"On behalf of the GEICAM 9906 Study Investigators","raw_affiliation_strings":[],"raw_orcid":null,"affiliations":[]}],"institutions":[],"countries_distinct_count":0,"institutions_distinct_count":0,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":{"value":5436,"currency":"USD","value_usd":5436},"apc_paid":{"value":5436,"currency":"USD","value_usd":5436},"fwci":7.6643,"has_fulltext":true,"cited_by_count":240,"citation_normalized_percentile":{"value":0.97658489,"is_in_top_1_percent":false,"is_in_top_10_percent":true},"cited_by_percentile_year":{"min":97,"max":100},"biblio":{"volume":"100","issue":"11","first_page":"805","last_page":"814"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T10183","display_name":"Breast Cancer Treatment Studies","score":0.9843999743461609,"subfield":{"id":"https://openalex.org/subfields/1306","display_name":"Cancer Research"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},"topics":[{"id":"https://openalex.org/T10183","display_name":"Breast Cancer Treatment Studies","score":0.9843999743461609,"subfield":{"id":"https://openalex.org/subfields/1306","display_name":"Cancer Research"},"field":{"id":"https://openalex.org/fields/13","display_name":"Biochemistry, Genetics and Molecular Biology"},"domain":{"id":"https://openalex.org/domains/1","display_name":"Life Sciences"}},{"id":"https://openalex.org/T11752","display_name":"Cancer Treatment and Pharmacology","score":0.015300000086426735,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}},{"id":"https://openalex.org/T10696","display_name":"Gastric Cancer Management and Outcomes","score":9.999999747378752e-05,"subfield":{"id":"https://openalex.org/subfields/2730","display_name":"Oncology"},"field":{"id":"https://openalex.org/fields/27","display_name":"Medicine"},"domain":{"id":"https://openalex.org/domains/4","display_name":"Health Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/early-breast-cancer","display_name":"early breast cancer","score":0.9779999852180481},{"id":"https://openalex.org/keywords/adjuvant-chemotherapy","display_name":"adjuvant chemotherapy","score":0.8849999904632568},{"id":"https://openalex.org/keywords/fec","display_name":"FEC","score":0.33500000834465027},{"id":"https://openalex.org/keywords/paclitaxel","display_name":"paclitaxel","score":0.9710000157356262},{"id":"https://openalex.org/keywords/taxanes","display_name":"taxanes","score":0.7319999933242798},{"id":"https://openalex.org/keywords/disease-free-survival","display_name":"disease-free survival","score":0.906000018119812},{"id":"https://openalex.org/keywords/overall-survival","display_name":"overall survival","score":0.7839999794960022},{"id":"https://openalex.org/keywords/lymph-node-positive-disease","display_name":"lymph node-positive disease","score":0.6499999761581421},{"id":"https://openalex.org/keywords/hormone-receptor-status","display_name":"hormone receptor status","score":0.7409999966621399},{"id":"https://openalex.org/keywords/her2-status","display_name":"HER2 status","score":0.8759999871253967},{"id":"https://openalex.org/keywords/prognostic-factors","display_name":"prognostic factors","score":0.7639999985694885},{"id":"https://openalex.org/keywords/predictive-biomarkers","display_name":"predictive biomarkers","score":0.7749999761581421},{"id":"https://openalex.org/keywords/risk-of-relapse","display_name":"relapse risk","score":0.5180000066757202},{"id":"https://openalex.org/keywords/tumor-size","display_name":"tumor size","score":0.5},{"id":"https://openalex.org/keywords/menopausal-status","display_name":"menopausal status","score":0.5640000104904175},{"id":"https://openalex.org/keywords/tamoxifen","display_name":"tamoxifen","score":0.4650000035762787},{"id":"https://openalex.org/keywords/trastuzumab","display_name":"trastuzumab","score":0.6840000152587891},{"id":"https://openalex.org/keywords/aromatase-inhibitors","display_name":"aromatase inhibitors","score":0.43299999833106995}],"concepts":[{"id":"https://openalex.org/C2780835546","wikidata":"https://www.wikidata.org/wiki/Q425122","display_name":"Epirubicin","level":4,"score":0.8902692794799805},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.832391619682312},{"id":"https://openalex.org/C530470458","wikidata":"https://www.wikidata.org/wiki/Q128581","display_name":"Breast cancer","level":3,"score":0.6992067098617554},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.6919103860855103},{"id":"https://openalex.org/C143998085","wikidata":"https://www.wikidata.org/wiki/Q162555","display_name":"Oncology","level":1,"score":0.6512569785118103},{"id":"https://openalex.org/C207103383","wikidata":"https://www.wikidata.org/wiki/Q3930246","display_name":"Hazard ratio","level":3,"score":0.6408406496047974},{"id":"https://openalex.org/C2780456651","wikidata":"https://www.wikidata.org/wiki/Q238512","display_name":"Fluorouracil","level":3,"score":0.5352106094360352},{"id":"https://openalex.org/C2776755627","wikidata":"https://www.wikidata.org/wiki/Q408524","display_name":"Cyclophosphamide","level":3,"score":0.5269423723220825},{"id":"https://openalex.org/C203092338","wikidata":"https://www.wikidata.org/wiki/Q1340863","display_name":"Clinical endpoint","level":3,"score":0.5009574890136719},{"id":"https://openalex.org/C50382708","wikidata":"https://www.wikidata.org/wiki/Q223218","display_name":"Proportional hazards model","level":2,"score":0.4561637043952942},{"id":"https://openalex.org/C2776694085","wikidata":"https://www.wikidata.org/wiki/Q974135","display_name":"Chemotherapy","level":2,"score":0.41081953048706055},{"id":"https://openalex.org/C2780849966","wikidata":"https://www.wikidata.org/wiki/Q170758","display_name":"Lymph node","level":2,"score":0.4105822443962097},{"id":"https://openalex.org/C121608353","wikidata":"https://www.wikidata.org/wiki/Q12078","display_name":"Cancer","level":2,"score":0.3350127339363098},{"id":"https://openalex.org/C141071460","wikidata":"https://www.wikidata.org/wiki/Q40821","display_name":"Surgery","level":1,"score":0.3240453004837036},{"id":"https://openalex.org/C44249647","wikidata":"https://www.wikidata.org/wiki/Q208498","display_name":"Confidence interval","level":2,"score":0.3084558844566345},{"id":"https://openalex.org/C168563851","wikidata":"https://www.wikidata.org/wiki/Q1436668","display_name":"Randomized controlled trial","level":2,"score":0.2926819324493408}],"mesh":[{"descriptor_ui":"D000328","descriptor_name":"Adult","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000368","descriptor_name":"Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000971","descriptor_name":"Antineoplastic Combined Chemotherapy Protocols","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D000971","descriptor_name":"Antineoplastic Combined Chemotherapy Protocols","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D000971","descriptor_name":"Antineoplastic Combined Chemotherapy Protocols","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D000972","descriptor_name":"Antineoplastic Agents, Phytogenic","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D000972","descriptor_name":"Antineoplastic Agents, Phytogenic","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D000972","descriptor_name":"Antineoplastic Agents, Phytogenic","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D001943","descriptor_name":"Breast Neoplasms","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D001943","descriptor_name":"Breast Neoplasms","qualifier_ui":"Q000473","qualifier_name":"pathology","is_major_topic":true},{"descriptor_ui":"D001943","descriptor_name":"Breast Neoplasms","qualifier_ui":"Q000737","qualifier_name":"chemistry","is_major_topic":false},{"descriptor_ui":"D003520","descriptor_name":"Cyclophosphamide","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D004334","descriptor_name":"Drug Administration Schedule","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D005472","descriptor_name":"Fluorouracil","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D007150","descriptor_name":"Immunohistochemistry","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D007262","descriptor_name":"Infusions, Intravenous","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008875","descriptor_name":"Middle Aged","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D009367","descriptor_name":"Neoplasm Staging","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D011237","descriptor_name":"Predictive Value of Tests","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D011379","descriptor_name":"Prognosis","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D011960","descriptor_name":"Receptors, Estrogen","qualifier_ui":"Q000032","qualifier_name":"analysis","is_major_topic":false},{"descriptor_ui":"D011980","descriptor_name":"Receptors, Progesterone","qualifier_ui":"Q000032","qualifier_name":"analysis","is_major_topic":false},{"descriptor_ui":"D014408","descriptor_name":"Biomarkers, Tumor","qualifier_ui":"Q000032","qualifier_name":"analysis","is_major_topic":true},{"descriptor_ui":"D015251","descriptor_name":"Epirubicin","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D016016","descriptor_name":"Proportional Hazards Models","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D016896","descriptor_name":"Treatment Outcome","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D017239","descriptor_name":"Paclitaxel","qualifier_ui":"Q000008","qualifier_name":"administration & dosage","is_major_topic":false},{"descriptor_ui":"D017239","descriptor_name":"Paclitaxel","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D017239","descriptor_name":"Paclitaxel","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D017404","descriptor_name":"In Situ Hybridization, Fluorescence","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D018270","descriptor_name":"Carcinoma, Ductal, Breast","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":false},{"descriptor_ui":"D018270","descriptor_name":"Carcinoma, Ductal, Breast","qualifier_ui":"Q000556","qualifier_name":"secondary","is_major_topic":false},{"descriptor_ui":"D018275","descriptor_name":"Carcinoma, Lobular","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":false},{"descriptor_ui":"D018275","descriptor_name":"Carcinoma, Lobular","qualifier_ui":"Q000556","qualifier_name":"secondary","is_major_topic":false},{"descriptor_ui":"D018572","descriptor_name":"Disease-Free Survival","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D018719","descriptor_name":"Erb-b2 Receptor Tyrosine Kinases","qualifier_ui":"Q000032","qualifier_name":"analysis","is_major_topic":false},{"descriptor_ui":"D053208","descriptor_name":"Kaplan-Meier Estimate","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":6,"locations":[{"id":"doi:10.1093/jnci/djn151","doi":"https://doi.org/10.1093/jnci/djn151","is_oa":true,"landing_page_url":"https://doi.org/10.1093/jnci/djn151","pdf_url":"https://academic.oup.com/jnci/article-pdf/100/11/805/7682226/djn151.pdf","source":{"id":"https://openalex.org/S98010888","display_name":"JNCI Journal of the National Cancer Institute","issn_l":"0027-8874","issn":["0027-8874","1460-2105"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-b","doyens","jufo-3","ki-jl-2","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310311648","host_organization_name":"Oxford University Press","host_organization_lineage":["https://openalex.org/P4310311648","https://openalex.org/P4310311647"],"host_organization_lineage_names":["Oxford University Press","University of Oxford"],"type":"journal"},"license":"cc-by-nc","license_id":"https://openalex.org/licenses/cc-by-nc","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"JNCI Journal of the National Cancer Institute","raw_type":"journal-article"},{"id":"pmid:18505968","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/18505968","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of the National Cancer Institute","raw_type":"Clinical Trial, Phase III"},{"id":"pmh:oai:CiteSeerX.psu:10.1.1.495.9530","doi":null,"is_oa":false,"landing_page_url":"http://citeseerx.ist.psu.edu/viewdoc/summary?doi=10.1.1.495.9530","pdf_url":null,"source":null,"license":null,"license_id":null,"version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"http://jnci.oxfordjournals.org/content/100/11/805.full.pdf","raw_type":"text"},{"id":"pmh:oai:CiteSeerX.psu:10.1.1.851.8526","doi":null,"is_oa":false,"landing_page_url":"http://citeseerx.ist.psu.edu/viewdoc/summary?doi=10.1.1.851.8526","pdf_url":null,"source":null,"license":null,"license_id":null,"version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"http://jnci.oxfordjournals.org/content/early/2008/05/27/jnci.djn151.full.pdf","raw_type":"text"},{"id":"pmh:oai:open-archive.highwire.org:jnci:djn151v1","doi":null,"is_oa":false,"landing_page_url":"http://jnci.oxfordjournals.org/cgi/content/short/djn151v1","pdf_url":null,"source":{"id":"https://openalex.org/S4406923041","display_name":"HighWire Press Open Archive","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"","raw_type":"TEXT"},{"id":"pmh:oai:www.repositoriosalud.es:10668/749","doi":null,"is_oa":true,"landing_page_url":"http://hdl.handle.net/10668/749","pdf_url":null,"source":{"id":"https://openalex.org/S4377196114","display_name":"RISalud Institutional Health Repository of Andaluc\u00eda","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":null,"host_organization_name":null,"host_organization_lineage":[],"host_organization_lineage_names":[],"type":"repository"},"license":"other-oa","license_id":"https://openalex.org/licenses/other-oa","version":"submittedVersion","is_accepted":false,"is_published":false,"raw_source_name":"","raw_type":"research article"}],"best_oa_location":{"id":"doi:10.1093/jnci/djn151","doi":"https://doi.org/10.1093/jnci/djn151","is_oa":true,"landing_page_url":"https://doi.org/10.1093/jnci/djn151","pdf_url":"https://academic.oup.com/jnci/article-pdf/100/11/805/7682226/djn151.pdf","source":{"id":"https://openalex.org/S98010888","display_name":"JNCI Journal of the National Cancer Institute","issn_l":"0027-8874","issn":["0027-8874","1460-2105"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["anvur-scientific","cwts-core","dongbi-b","doyens","jufo-3","ki-jl-2","medline","norway-2","poland-200","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310311648","host_organization_name":"Oxford University Press","host_organization_lineage":["https://openalex.org/P4310311648","https://openalex.org/P4310311647"],"host_organization_lineage_names":["Oxford University Press","University of Oxford"],"type":"journal"},"license":"cc-by-nc","license_id":"https://openalex.org/licenses/cc-by-nc","version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"JNCI Journal of the National Cancer Institute","raw_type":"journal-article"},"sustainable_development_goals":[{"id":"https://metadata.un.org/sdg/3","score":1.0,"display_name":"Good health and well-being"}],"study_designs":[{"id":"https://openalex.org/study-designs/randomized-controlled-trial","display_name":"Randomized Controlled Trial"},{"id":"https://openalex.org/study-designs/clinical-trial","display_name":"Clinical Trial"}],"awards":[],"funders":[],"has_content":{"grobid_xml":true,"pdf":true},"content_urls":{"pdf":"https://content.openalex.org/works/W2117239059.pdf","grobid_xml":"https://content.openalex.org/works/W2117239059.grobid-xml"},"referenced_works_count":27,"referenced_works":["https://openalex.org/W267005183","https://openalex.org/W1262485082","https://openalex.org/W1848579801","https://openalex.org/W1961026612","https://openalex.org/W1974527689","https://openalex.org/W1979300931","https://openalex.org/W2009740420","https://openalex.org/W2012920290","https://openalex.org/W2014637687","https://openalex.org/W2050629268","https://openalex.org/W2075213874","https://openalex.org/W2078881615","https://openalex.org/W2091205535","https://openalex.org/W2096471659","https://openalex.org/W2096864872","https://openalex.org/W2098333537","https://openalex.org/W2104528117","https://openalex.org/W2115432999","https://openalex.org/W2127232551","https://openalex.org/W2133714238","https://openalex.org/W2135800076","https://openalex.org/W2138440511","https://openalex.org/W2167926320","https://openalex.org/W2214029008","https://openalex.org/W2231000545","https://openalex.org/W2247641735","https://openalex.org/W3041047318"],"related_works":["https://openalex.org/W2028496627","https://openalex.org/W2119486061","https://openalex.org/W2193011618","https://openalex.org/W2089606677","https://openalex.org/W2589524476","https://openalex.org/W7095601828","https://openalex.org/W2024076124","https://openalex.org/W2329183416","https://openalex.org/W2124268018","https://openalex.org/W1980544879"],"abstract_inverted_index":{"BACKGROUND:":[0],"Taxanes":[1],"are":[2],"among":[3],"the":[4,9,25,77,113,145,159,165,191,202,206,213,217,239,261,343],"most":[5],"active":[6],"drugs":[7],"for":[8,110,112,264],"treatment":[10,42,183,198,322,339],"of":[11,60,76,82,125,151,193,241,272,281,345],"metastatic":[12],"breast":[13,30,336],"cancer,":[14,337],"and,":[15],"as":[16,350],"a":[17,104,187,235],"consequence,":[18],"they":[19],"have":[20],"also":[21],"been":[22],"studied":[23],"in":[24,94,158,164,190,201,205,212,216,238],"adjuvant":[26,351],"setting.":[27],"METHODS:":[28],"After":[29],"cancer":[31],"surgery,":[32],"women":[33],"with":[34,43,50,103,186,196,309,334,348],"lymph":[35,121,130,284],"node-positive":[36],"disease":[37],"were":[38,101,141,156,268,306],"randomly":[39],"assigned":[40],"to":[41,177,229,255],"fluorouracil,":[44],"epirubicin,":[45],"and":[46,74,79,84,90,99,134,162,234,244,300,320,328],"cyclophosphamide":[47],"(FEC)":[48],"or":[49,323],"FEC":[51,166,197,218,349],"followed":[52],"by":[53,66,88,92],"weekly":[54],"paclitaxel":[55,321,329],"(FEC-P).":[56],"The":[57],"primary":[58],"endpoint":[59],"study-5-year":[61],"disease-free":[62],"survival":[63,73],"(DFS)-was":[64],"assessed":[65,102],"Kaplan-Meier":[67],"analysis.":[68],"Secondary":[69],"endpoints":[70],"included":[71],"overall":[72],"analysis":[75],"prognostic":[78],"predictive":[80],"value":[81],"clinical":[83],"molecular":[85],"(hormone":[86],"receptors":[87],"immunohistochemistry":[89],"HER2":[91,132,301,318],"fluorescence":[93],"situ":[95],"hybridization)":[96],"markers.":[97],"Associations":[98],"interactions":[100],"multivariable":[105],"Cox":[106],"proportional":[107],"hazards":[108],"model":[109],"DFS":[111,152],"following":[114],"covariates:":[115],"age,":[116],"menopausal":[117],"status,":[118,123,133],"tumor":[119,127,266,289],"size,":[120,128],"node":[122],"type":[124,271],"chemotherapy,":[126],"positive":[129],"nodes,":[131],"hormone":[135,294,325],"receptor":[136,295,326],"status.":[137],"All":[138],"statistical":[139],"tests":[140],"two-sided.":[142],"RESULTS:":[143],"Among":[144,260,332],"1246":[146],"eligible":[147],"patients,":[148],"estimated":[149],"rates":[150],"at":[153],"5":[154],"years":[155],"78.5%":[157],"FEC-P":[160,182,207,338],"arm":[161,167,208],"72.1%":[163],"(difference":[168],"=":[169,175,180,223,227,232,249,253,258,278,292,298,304],"6.4%,":[170],"95%":[171,225,251],"confidence":[172],"interval":[173],"[CI]":[174],"1.6%":[176],"11.2%;":[178],"P":[179,231,257],".006).":[181],"was":[184],"associated":[185,308],"23%":[188],"reduction":[189,237],"risk":[192,240,344],"relapse":[194,346],"compared":[195,347],"(146":[199],"relapses":[200,211],"614":[203],"patients":[204,215,263,333],"vs":[209,275],"193":[210],"632":[214],"arm,":[219],"hazard":[220],"ratio":[221],"[HR]":[222],"0.77,":[224],"CI":[226,252],"0.62":[228],"0.95;":[230],".022)":[233],"22%":[236],"death":[242],"(73":[243],"95":[245],"deaths,":[246],"respectively,":[247],"HR":[248],"0.78,":[250],"0.57":[254],"1.06;":[256],".110).":[259],"928":[262],"whom":[265],"samples":[267],"centrally":[269],"analyzed,":[270],"chemotherapy":[273],"(FEC":[274],"FEC-P)":[276],"(P":[277,286,291,297,303],".017),":[279],"number":[280],"involved":[282],"axillary":[283],"nodes":[285],"<":[287],".001),":[288],"size":[290],".020),":[293],"status":[296,302,319,327],".004),":[299],".006)":[305],"all":[307],"DFS.":[310],"We":[311],"found":[312],"no":[313],"statistically":[314,340],"significant":[315],"interaction":[316],"between":[317,324],"treatment.":[330],"CONCLUSIONS:":[331],"operable":[335],"significantly":[341],"reduced":[342],"therapy.":[352]},"counts_by_year":[{"year":2026,"cited_by_count":4},{"year":2025,"cited_by_count":5},{"year":2024,"cited_by_count":7},{"year":2023,"cited_by_count":5},{"year":2022,"cited_by_count":7},{"year":2021,"cited_by_count":5},{"year":2020,"cited_by_count":7},{"year":2019,"cited_by_count":14},{"year":2018,"cited_by_count":15},{"year":2017,"cited_by_count":10},{"year":2016,"cited_by_count":15},{"year":2015,"cited_by_count":18},{"year":2014,"cited_by_count":21},{"year":2013,"cited_by_count":22},{"year":2012,"cited_by_count":15}],"updated_date":"2026-11-07T11:25:07.637180","created_date":"2016-06-24T00:00:00"}